Fig. 4
Number of subjects from each diagnostic group per meta-sequence stage. Each step along the x-axis corresponds to the occurrence of a new biomarker abnormality event. Stage 0 corresponds to no event occurrence while the last stage implies abnormality of all variables. Events are ordered according to the bootstrapped meta-sequence, always considering only variables in common between the measurements available in the respective cohort and the meta-sequence